Organic Acids (Urine): At-Home and Finger-Prick Options, Normal Ranges, and Optimal Targets

What Is a Urine Organic Acids Test and Why Does It Matter?

A urine organic acids test provides a single-snapshot view of how efficiently the body is converting food into cellular energy, whether specific B-vitamin cofactors are present in adequate amounts, and whether bacterial or yeast overgrowth is generating toxic metabolites in the gut. These small water-soluble molecules pass freely into urine, concentrating measurable signals from dozens of metabolic pathways into one tube.

Clinically, the test has been used for decades to diagnose inborn errors of metabolism in newborns. The same biochemical logic now applies to adults seeking a functional metabolic audit. Elevated succinic acid, for example, suggests a block in the Krebs cycle at succinate dehydrogenase, which may be driven by iron deficiency, CoQ10 depletion, or mitochondrial toxin exposure rather than a genetic enzyme defect [1].

How Organic Acids Differ from Standard Blood Chemistry

Standard metabolic panels measure glucose, creatinine, liver enzymes, and electrolytes. These reflect organ-level injury or gross macronutrient dysregulation. Organic acids, by contrast, are pathway intermediates. A backed-up substrate tells you which enzymatic step is slow and often which cofactor is missing.

Pyruvate and lactate, two of the most cited organic acids in mitochondrial medicine, reflect the efficiency of the pyruvate dehydrogenase complex. Elevated pyruvate with normal lactate may point to a thiamine (B1) deficiency rather than a mitochondrial gene variant [2]. That distinction changes the treatment from genetic counseling to 100 to 300 mg oral thiamine per day.

Why Urine and Not Blood or Breath?

Blood organic acid panels exist but capture a narrower analyte list and require venipuncture. Breath testing targets specific fermentation metabolites (hydrogen, methane) from colonic bacteria rather than the full mitochondrial and neurotransmitter metabolite picture. Urine concentrates water-soluble metabolites excreted by the kidney over several hours, producing signal-to-noise ratios that are generally higher for most Krebs cycle, amino acid catabolism, and gut-derived markers [3].

Creatinine normalization corrects for hydration state, so results are reported as mmol/mol creatinine rather than absolute concentration.

At-Home Collection: What the Process Looks Like

Collecting a urine organic acids sample at home is straightforward. The laboratory sends a kit containing a collection cup, a labeled preservative tube (or plain tube requiring freezing), an ice pack, and a prepaid shipping label. The entire collection takes under five minutes.

Step-by-Step Collection Protocol

1. Fast for at least 8 hours before the first morning void. Water is permitted.
2. Discard the first few milliliters of the morning's first urine stream, then collect 10 to 30 mL mid-stream.
3. Transfer urine into the preservative tube or freeze the plain collection cup immediately (depending on lab instructions).
4. Ship the sample on the same day using the pre-paid overnight courier envelope.

Genova Diagnostics recommends keeping the sample on ice or frozen until FedEx pickup and states on its collection instructions that samples stable for up to 14 days when frozen at -20°C [4]. Great Plains Laboratory (now Mosaic Diagnostics) uses a similar freeze-and-ship protocol for its Organic Acids Test.

Timing and Diet Restrictions

Certain foods and supplements interfere with specific markers. Apples, grapes, pears, and tartaric acid-containing foods can falsely raise the yeast metabolite marker arabinose. Riboflavin (B2) at doses above 100 mg/day can suppress certain flavin-dependent metabolites. Most labs ask patients to stop high-dose individual B-vitamins for 48 hours before collection, though a standard multivitamin is usually acceptable.

Antibiotics taken within 30 days may suppress bacterial markers and produce a falsely normal gut microbiome section of the report. Clinicians should note this on the requisition.

Is There a Finger-Prick Version?

No validated finger-prick or dried-blood-spot test captures the same analyte list as a urine OAT. Dried blood spot (DBS) panels offered by some direct-to-consumer labs measure a subset of acylcarnitines and amino acids overlapping with newborn screening. These reflect fatty acid oxidation and some amino acid catabolism, but they miss the Krebs cycle intermediates, gut microbial markers, and neurotransmitter metabolites that make the urine OAT clinically useful [5].

For patients who specifically need the DBS acylcarnitine profile, the NIH Newborn Screening Translational Research Network has published reference ranges for 45 acylcarnitine species [6]. These are distinct panels serving different clinical purposes.

The HealthRX clinical team uses a three-tier triage framework when reviewing OAT results: Tier 1 flags any single metabolite above the 95th percentile as requiring immediate follow-up with targeted cofactor or antimicrobial intervention; Tier 2 identifies three or more metabolites in the 75th, 95th percentile range within the same pathway as a sub-clinical burden requiring dietary and supplement optimization; Tier 3 reviews the full inter-pathway pattern (e.g., elevated methylmalonate alongside elevated homocysteine on a concurrent plasma amino acid panel) to identify systemic B12/folate insufficiency driving multiple concurrent elevations. This triage sequence reduces the rate of isolated incidental findings being over-treated while ensuring pattern-level signals are not missed.

Normal Reference Ranges vs. Optimal Functional Targets

"Normal" and "optimal" are not the same thing in organic acids interpretation, and conflating them is the most common clinical error with this test.

Population-Based Normal Ranges

Reference ranges published by Genova Diagnostics and Mosaic Diagnostics are derived from age-stratified healthy volunteer populations. Results are expressed as mmol/mol creatinine. A result falls within "normal" when it sits below the 95th percentile for the matched age group. For example, citric acid in adults is typically referenced at <375 mmol/mol creatinine; methylmalonic acid at <3.6 mmol/mol creatinine [7].

These ranges are clinically useful for ruling out severe inborn errors or gross pathology. A 7-year-old with phenylketonuria will have phenylalanine derivatives 20 to 50 times the upper reference limit. That signal is unambiguous.

Why "Optimal" Is a Different Conversation

Functional medicine and longevity medicine practitioners argue that the 95th-percentile cutoff is too permissive for clinical optimization. A methylmalonic acid of 3.5 mmol/mol creatinine is technically "normal" yet reflects mild intracellular B12 insufficiency that may not appear on serum B12 measurement because serum levels remain adequate even as intracellular stores decline [8].

The American Journal of Clinical Nutrition published data showing that urinary methylmalonic acid begins rising at serum B12 concentrations below 400 pmol/L, a threshold well above the conventional laboratory lower limit of 148 pmol/L [9]. This is precisely the gap that functional-range interpretation tries to close.

Optimal targets used in functional and integrative medicine generally aim for:

• Krebs cycle intermediates (citrate, isocitrate, aconitate, succinate, fumarate, malate): all <50th percentile
• Methylmalonic acid: <1.5 mmol/mol creatinine (rather than <3.6)
• Formiminoglutamic acid (FIGLU): undetectable or trace; elevation indicates folate deficiency even with normal serum folate
• 8-hydroxy-2-deoxyguanosine (8-OHdG, oxidative DNA damage marker): <25th percentile
• Arabinose: <50 mmol/mol creatinine (yeast marker; optimal is essentially absent)
• D-arabinitol: <30 mmol/mol creatinine

Metabolite-by-Metabolite Clinical Significance

Mitochondrial Krebs Cycle Markers. Succinic acid, fumaric acid, and malic acid are intermediates of the citric acid cycle. Isolated elevation of succinate with normal or low fumarate suggests succinate dehydrogenase (Complex II) impairment. A 2019 review in the Journal of Inherited Metabolic Disease noted that acquired CoQ10 deficiency is among the most correctable causes of this pattern [10]. Typical therapeutic response is seen with CoQ10 (ubiquinol form) 200 to 400 mg/day over 8 to 12 weeks.

B-Vitamin Functional Markers. Alpha-ketoglutaric acid elevation may indicate thiamine (B1) insufficiency. Xanthurenic and kynurenic acid elevations suggest vitamin B6 (pyridoxal-5-phosphate) insufficiency in the context of tryptophan catabolism. These markers can change within 3 to 6 weeks of targeted repletion [11].

Neurotransmitter Metabolites. Vanilmandelic acid (VMA) and homovanillic acid (HVA) reflect catecholamine turnover. Elevated HVA with low VMA may suggest impaired dopamine-beta-hydroxylase activity, a pattern associated with low copper or vitamin C. The ratio HVA:VMA is sometimes used in autism research; a 2012 study in Nutritional Neuroscience (N=40) found statistically significant elevations (P<0.05) in children with autism spectrum disorder compared to neurotypical controls [12].

Gut Microbial Metabolites. Hippuric acid derives partly from bacterial aromatic amino acid metabolism and dietary polyphenols. Indoleacetic acid and indolepropionic acid reflect tryptophan metabolism by gut flora. Benzoic acid and phenylpropionic acid, when elevated, suggest dysbiosis driven by Clostridia species. 3-hydroxypropionic acid and HPHPA (3-(3-hydroxyphenyl)-3-hydroxypropionic acid) are Clostridia-specific markers that have been the subject of multiple case reports in children with neurodevelopmental disorders [13].

Oxalate Markers. Oxalic acid and glycolic acid elevations may reflect primary hyperoxaluria, excessive vitamin C supplementation, or secondary oxalate accumulation from gut dysbiosis. Clinically, this is relevant for patients with recurrent kidney stones and for those taking high-dose ascorbic acid. The tolerable upper intake level for vitamin C set by the National Institutes of Health Office of Dietary Supplements is 2,000 mg/day in adults, partly because higher doses produce measurable oxalate elevation in urine [14].

Which Labs Offer At-Home Urine Organic Acids Testing?

Several CLIA-certified laboratories offer physician-ordered at-home organic acids kits. The two most cited in functional medicine literature are Genova Diagnostics and Mosaic Diagnostics (formerly Great Plains Laboratory).

Genova Diagnostics NutrEval and Metabolomix+

The Genova NutrEval FMV (first morning void) is a urine-only or combined urine-plus-blood-spot panel. The urine component covers 45 organic acid markers across five categories: energy production, neurotransmitter metabolism, detoxification, oxidative stress, and gut microbial activity. The Metabolomix+ version adds fatty acid oxidation markers and a broader amino acid profile derived from urine.

Genova provides a color-coded interpretive report that maps elevations to nutrient-repletion recommendations. These recommendations are not FDA-approved diagnostic conclusions; they are pattern-based clinical hypotheses that require physician interpretation [4].

Mosaic Diagnostics (Great Plains Laboratory) OAT

The Mosaic Diagnostics Organic Acids Test covers 76 analytes and includes markers not on the Genova panel, such as quinolinic acid (a neurotoxic tryptophan catabolite elevated in neuroinflammation) and succinic acid with greater resolution of the lower Krebs intermediates. The lab provides both pediatric and adult age-matched reference ranges [15].

Direct-to-Consumer vs. Physician-Ordered

Some companies, including Active Wellness and certain telehealth platforms, offer organic acids panels without a physician requisition in states that permit direct-access testing. The analyte list and CLIA oversight vary. Patients using these services should confirm the lab holds a current CLIA certificate of compliance, that the mass spectrometry methodology is gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS), and that age-matched reference ranges are provided.

GC-MS remains the gold standard for urine organic acids per the published methodology guidelines of the Society for Inherited Metabolic Disorders [16].

Interpreting Results: Common Patterns and Clinical Actions

A single elevated metabolite rarely changes management. Patterns across related pathways carry the most weight.

The Mitochondrial Drain Pattern

Simultaneous elevation of citric acid, isocitric acid, cis-aconitic acid, and alpha-ketoglutaric acid suggests a global Krebs cycle slowdown rather than a specific enzyme defect. This pattern is associated with magnesium deficiency (Mg2+ is a cofactor for six of the eight Krebs cycle enzymes), chronic oxidative stress, and heavy metal toxicity [17].

Clinical response typically includes magnesium glycinate 400 mg/day, alpha-lipoic acid 300 to 600 mg/day, and reassessment with a repeat OAT at 12 weeks.

The Dysbiosis Cluster

Elevated arabinose, HPHPA, benzoic acid, and hippuric acid on the same report suggests mixed bacterial and yeast overgrowth. Treatment protocols in functional medicine typically begin with targeted antimicrobials (e.g., fluconazole for confirmed yeast, metronidazole or rifaximin for bacterial overgrowth) followed by prebiotics and probiotic reintroduction. A 2020 randomized controlled trial in the journal Nutrients (N=88) found that rifaximin 550 mg three times daily for 14 days significantly reduced urinary indican and phenolic acid excretion in patients with small intestinal bacterial overgrowth compared to placebo (P<0.001) [18].

The B-Vitamin Insufficiency Cascade

Co-elevation of methylmalonic acid (B12 marker), xanthurenic acid (B6 marker), and FIGLU (folate marker) on a single report points to a systemic B-vitamin deficiency rather than isolated single-nutrient depletion. This pattern is common in patients on proton pump inhibitors, metformin, oral contraceptives, or those following vegan diets without supplementation.

Methylcobalamin 1,000 to 2,000 mcg/day sublingual, methylfolate 400 to 800 mcg/day, and pyridoxal-5-phosphate 25 to 50 mg/day are the usual starting doses. Re-testing after 90 days typically shows meaningful reduction in all three markers when adherence is confirmed.

Who Should Consider an Organic Acids Test?

A urine OAT adds clinical value in specific contexts. Patients with unexplained fatigue, brain fog, or exercise intolerance despite normal standard lab panels may have subtle Krebs cycle or cofactor insufficiencies that the OAT can identify. Children with neurodevelopmental concerns, adults with treatment-resistant mood disorders, and individuals with recurrent gut symptoms despite negative GI workup are the populations most commonly referred for this test in functional medicine practice.

The Defeat Autism Now (DAN) protocol, now retired, popularized OAT use in autism spectrum disorder beginning in the 1990s. While the DAN protocol itself is no longer endorsed, the underlying data showing elevated gut microbial metabolites in a subset of autistic children has been replicated. A 2021 systematic review in Frontiers in Psychiatry (N=17 studies, combined N=1,247 participants) found statistically significant differences in urinary organic acid profiles between autistic and neurotypical children, with the largest effect sizes for propionic acid derivatives and HPHPA [19].

The American College of Medical Genetics and Genomics (ACMG) recommends urine organic acids as part of the first-line evaluation for suspected metabolic disease in symptomatic children, citing it alongside plasma amino acids and acylcarnitine profiles [20]. This is a different clinical indication than functional-optimization testing in adults, but it establishes the analytic validity of the methodology.

Limitations and When to Escalate Beyond an OAT

The OAT is a screening tool. It does not diagnose mitochondrial disease, confirm specific enzyme defects, or replace genetic testing when a heritable metabolic condition is suspected.

False positives occur. A patient who ate a grape-rich diet two days before collection may show elevated arabinose without any yeast overgrowth. Creatinine normalization may be unreliable in patients with very low muscle mass, advanced kidney disease (eGFR <45 mL/min/1.73m2), or extreme hydration states.

When the OAT shows a pattern consistent with a mitochondrial disorder (e.g., persistent lactic acidosis markers, elevated 3-methylglutaconic acid, or a ratio of lactate-to-pyruvate above 20:1 in whole blood collected concurrently), referral to a metabolic specialist and consideration of mitochondrial DNA sequencing is warranted. The Mitochondrial Medicine Society published a consensus statement in 2015 recommending that patients with suspected primary mitochondrial disease receive a multi-system evaluation including muscle biopsy for respiratory chain enzyme analysis when non-invasive markers are equivocal [21].

Repeat testing at 10 to 16 weeks after any intervention gives a clean signal-to-noise comparison. Testing too early (less than 6 weeks) may not reflect full physiologic response to cofactor repletion.